CHRONIC LYMPHOCYTIC INFLAMMATION WITH PONTINE PERIVASCULAR ENHANCEMENT RESPONSIVE TO STEROIDS

This adverse event was reported 26 times

These drugs are most commonly taken by patients reporting CHRONIC LYMPHOCYTIC INFLAMMATION WITH PONTINE PERIVASCULAR ENHANCEMENT RESPONSIVE TO STEROIDS:

# Drug Count
0 METHYLPREDNISOLONE 10
1 MYCOPHENOLATE MOFETIL 8
2 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 8
3 PREDNISOLONE 6
4 PREDNISOLONE ORAL 6
5 PREDNISOLONE ORAL SOLUTION 6
6 ADALIMUMAB 4
7 ADALIMUMAB-AATY 4
8 ADALIMUMAB-ADAZ 4
9 ADALIMUMAB-FKJP 4
See all common drugs associated with CHRONIC LYMPHOCYTIC INFLAMMATION WITH PONTINE PERIVASCULAR ENHANCEMENT RESPONSIVE TO STEROIDS

CHRONIC LYMPHOCYTIC INFLAMMATION WITH PONTINE PERIVASCULAR ENHANCEMENT RESPONSIVE TO STEROIDS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TREOSULFAN 2 0.0007
1 CEMIPLIMAB-RWLC 1 0.0005
2 CEFIXIME 1 0.0003
3 RITUXIMAB-ABBS 1 0.0002
4 AMPICILLIN INJECTION 1 0.0001
5 REPAGLINIDE 1 0.0001
6 AMPICILLIN 1 0.0001
7 VANCOMYCIN HYDROCHLORIDE 1 0.0001
8 ALEMTUZUMAB 2 0.0001
9 ADALIMUMAB-FKJP 4 0.0001
See all drugs enriched for association with CHRONIC LYMPHOCYTIC INFLAMMATION WITH PONTINE PERIVASCULAR ENHANCEMENT RESPONSIVE TO STEROIDS